In your state
District of Columbia

In the development of new medicines, clinical trials are conducted to prove therapeutic safety and effectiveness and compile the evidence needed for the Food and Drug Administration (FDA) to approve treatments. And the biopharmaceutical sector is committed to bringing new treatments and cures to patients. This commitment to innovation supports high-quality jobs and is a vital part of every state’s economy and our global economic competitiveness.

Economic Impact In Your State: District of Columbia

$437M

Total output supported by biophamaceutical sector

$396,000

Total output supported by biophamaceutical sector

1,485

Total Jobs

637

Direct Jobs

Clinical Trials in Your State: District of Columbia

294

TOTAL CLINICAL TRIALS

$63.3 million

INVESTED IN CLINICAL TRIALS

4,433

TOTAL ECONOMIC IMPACT OF CLINICAL TRIAL INVESTMENTS

$106.9 million

INVESTED IN CLINICAL TRIALS

Programs and Initiatives in Your State: District of Columbia

State programs and initiatives to promote biopharmaceutical industry development